Vericel (VCEL) Cash & Current Investments (2010 - 2026)

Vericel's (VCEL) quarterly Cash & Current Investments came in at $145.3 million in Q1 2026, up 82.35% year-on-year from $79.7 million in Q1 2025, and up 5.7% quarter-over-quarter from $137.5 million in Q4 2025.

Vericel (VCEL) Cash & Current Investments (2010 - 2026) Analysis & Trends

Vericel has disclosed Cash & Current Investments across 15 years of filings, most recently posting $145.3 million for Q1 2026.

  • Cash & Current Investments for Q1 2026 came in at $145.3 million, up 82.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $145.3 million (up 82.35% YoY), and the FY2025 annual result was $137.5 million, up 18.32% from the prior year.
  • Cash & Current Investments came in at $145.3 million for Q1 2026 at Vericel, up from $137.5 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $145.3 million in Q1 2026 to a low of $51.1 million in Q4 2022.
  • The 5-year median for Cash & Current Investments is $100.7 million (2022), against an average of $101.7 million.
  • Across the five-year window, Cash & Current Investments plunged 50.61% in 2022 and surged 92.44% in 2025, its largest moves.
  • Vericel's Cash & Current Investments stood at $51.1 million in 2022, then jumped by 70.1% to $86.9 million in 2023, then jumped by 33.78% to $116.2 million in 2024, then gained by 18.32% to $137.5 million in 2025, then rose by 5.7% to $145.3 million in 2026.
  • The last three Cash & Current Investments figures came in at $145.3 million (Q1 2026), $137.5 million (Q4 2025), and $135.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.13 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.20 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 7.25 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Vericel 2.04 Bn 1.90 Bn 49.27 Mn 145.34 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 145.34 Mn
Dec 31, 2025 137.50 Mn
Sep 30, 2025 135.38 Mn
Jun 30, 2025 80.53 Mn
Mar 31, 2025 79.71 Mn
Dec 31, 2024 116.21 Mn
Sep 30, 2024 70.35 Mn
Jun 30, 2024 102.51 Mn
Mar 31, 2024 110.65 Mn
Dec 31, 2023 86.87 Mn
Sep 30, 2023 83.56 Mn
Jun 30, 2023 97.83 Mn
Mar 31, 2023 119.28 Mn
Dec 31, 2022 51.07 Mn
Sep 30, 2022 110.94 Mn
Jun 30, 2022 100.69 Mn
Mar 31, 2022 100.55 Mn
Dec 31, 2021 103.40 Mn
Sep 30, 2021 98.29 Mn
Jun 30, 2021 90.98 Mn